Phase II Avastin + Bortezomib for Patients With Recurrent Malignant Glioma
This study is ongoing, but not recruiting participants.
Sponsor:
Duke University
Collaborators:
Millennium Pharmaceuticals, Inc.
Genentech
Information provided by (Responsible Party):
Duke University
ClinicalTrials.gov Identifier:
NCT00611325
First received: January 28, 2008
Last updated: June 29, 2012
Last verified: June 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is ongoing, but not recruiting participants. |
|---|---|
| Estimated Study Completion Date: | August 2012 |
| Estimated Primary Completion Date: | August 2012 (Final data collection date for primary outcome measure) |